XTX Topco Ltd bought a new stake in shares of Surgery Partners, Inc. (NASDAQ:SGRY - Free Report) during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor bought 20,151 shares of the company's stock, valued at approximately $479,000.
A number of other large investors have also recently bought and sold shares of the stock. Janus Henderson Group PLC grew its holdings in Surgery Partners by 110.2% during the 4th quarter. Janus Henderson Group PLC now owns 11,554,845 shares of the company's stock valued at $244,616,000 after buying an additional 6,057,477 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of Surgery Partners by 18.7% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,577,861 shares of the company's stock worth $75,739,000 after purchasing an additional 563,812 shares during the period. King Street Capital Management L.P. lifted its stake in shares of Surgery Partners by 93.1% during the 4th quarter. King Street Capital Management L.P. now owns 2,800,000 shares of the company's stock worth $59,276,000 after purchasing an additional 1,350,000 shares during the period. Point72 Asset Management L.P. lifted its stake in shares of Surgery Partners by 224.7% during the 4th quarter. Point72 Asset Management L.P. now owns 1,746,554 shares of the company's stock worth $36,975,000 after purchasing an additional 1,208,639 shares during the period. Finally, Silvercrest Asset Management Group LLC lifted its stake in shares of Surgery Partners by 44.9% during the 4th quarter. Silvercrest Asset Management Group LLC now owns 998,505 shares of the company's stock worth $21,138,000 after purchasing an additional 309,481 shares during the period.
Surgery Partners Trading Up 0.5%
Shares of SGRY traded up $0.12 during trading hours on Tuesday, hitting $22.86. The stock had a trading volume of 224,434 shares, compared to its average volume of 1,403,845. The company has a debt-to-equity ratio of 1.10, a quick ratio of 1.78 and a current ratio of 1.93. The firm has a market cap of $2.93 billion, a P/E ratio of -15.99 and a beta of 1.82. The company's fifty day simple moving average is $22.14 and its 200 day simple moving average is $23.00. Surgery Partners, Inc. has a 12-month low of $18.87 and a 12-month high of $33.97.
Surgery Partners (NASDAQ:SGRY - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $0.17 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.01. The business had revenue of $826.20 million for the quarter, compared to analyst estimates of $816.96 million. Surgery Partners had a positive return on equity of 2.51% and a negative net margin of 5.57%. The business's quarterly revenue was up 8.4% on a year-over-year basis. During the same period last year, the company posted $0.21 EPS. Equities research analysts forecast that Surgery Partners, Inc. will post 0.67 EPS for the current fiscal year.
Analyst Ratings Changes
SGRY has been the topic of a number of recent analyst reports. Benchmark reissued a "buy" rating and set a $35.00 price target on shares of Surgery Partners in a research note on Monday, April 21st. Barclays reduced their price target on Surgery Partners from $25.00 to $24.00 and set an "equal weight" rating on the stock in a research note on Tuesday, May 27th. Finally, Bank of America initiated coverage on Surgery Partners in a research note on Monday, July 28th. They set a "buy" rating and a $28.00 price target on the stock. Three investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $33.00.
Get Our Latest Analysis on SGRY
About Surgery Partners
(
Free Report)
Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
Featured Articles

Before you consider Surgery Partners, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Surgery Partners wasn't on the list.
While Surgery Partners currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.